What You Should Know:
– Flatiron Health, a provider of real-world data (RWD) for cancer care, and the National Comprehensive Cancer Network® (NCCN®), an alliance of top cancer centers, have announced a renewal of their long-standing collaboration.
– This decade-long partnership, dating back to 2014, focuses on leveraging RWD to improve cancer care and research.
The Power of Real-World Data in Cancer Care
Real-world data offers a valuable window into the realities of cancer care beyond clinical trials. By analyzing data from real-world settings, researchers and healthcare providers can gain a deeper understanding of treatment effectiveness, identify potential disparities in care, and ultimately improve patient outcomes.
Collaboration for Better Cancer Care with RWD
The renewed collaboration signifies a continued commitment to leveraging RWD for positive impact. This will involve several key initiatives:
- Expanding Real-World Data Research: Flatiron and NCCN will work together to enable further research using RWD. This research will provide valuable insights into real-world treatment patterns and patient outcomes.
- Improving Cancer Care Nationwide: Cancer centers across the country will benefit from access to Flatiron’s high-quality, curated datasets. This data can be used to benchmark performance, identify areas for improvement, and ultimately deliver better care for patients.
- Enhancing Quality of Care: Flatiron and NCCN will continue collaborating on quality improvement initiatives for NCCN Member Institutions. This includes developing new metrics and benchmarks to assess and measure the quality of care provided.
“We strive to ensure that everyone, everywhere, is able to access high-quality cancer care based on the latest evidence and expert consensus,” said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. “This ongoing collaboration with Flatiron will help us leverage data in pursuit of that goal. We are happy to renew our commitment to work together to help people with cancer live better lives.”
